According to reports, AstraZeneca has already negotiated a merger with Bristol-Myers Squibb. People familiar with the matter said that these discussions took place in recent months and are still likely to come to an end. The report did not detail the exact structure of any potential deal. As of last Friday, the market capitalization of AstraZeneca and Bristol-Myers Squibb was £19.6 billion and $133 billion, respectively.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.